YOLFTbeta
PolyPeptide Group AG

PolyPeptide Group AG

PPGN · SW · Healthcare / Drug Manufacturers - Specialty & Generic

40.35CHF-0.05 (-0.12%)

Price History

Full chart

Market Stats

Previous Close40.40
Open40.35
Day Range40.35 – 40.50
52-Week Range21.80 – 50.10
Volume12.49K
Market Cap1.46B
P/E (TTM)107.56
Forward P/E34.84
EPS0.41
Dividend Yield0.00%
Beta1.00
50-Day Avg43.98
200-Day Avg35.77

About

PolyPeptide Group AG operates as a contract development and manufacturing company in Europe, the United States, Asia Pacific, and internationally. It develops and manufactures synthetic peptides used as active pharmaceutical ingredients or intermediates in therapeutic products. The company offers portfolio of drug therapies for metabolic diseases, including the GLP-1. It also provides generic peptides and peptides used in cosmetics, animal health, and medical devices, as well as development and analytical services. The company serves academic, pharmaceutical, and biotech companies. PolyPeptide Group AG was founded in 1952 and is headquartered in Baar, Switzerland. PolyPeptide Group AG is a subsidiary of Draupnir Holding B.V.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Juan Jose Gonzalez
  • Employees1.46K
  • HeadquartersNeuhofstrasse 24, Baar, Switzerland, 6340, Switzerland
  • Websitehttps://www.polypeptide.com

Leadership

  • Mr. Juan Jose GonzalezChief Executive Officer · b. 1972
  • Mr. Tim BrandlInterim CFO and Director of Investor Relations, Financial Planning & Analysis
  • Rene VestergaardDirector of Corporate Finance
  • Mr. Olivier Ludemann-HombourgerDirector of Global Innovation & Technology · b. 1972
  • Ms. Christina Del VecchioChief Legal Officer & Corporate Secretary · b. 1978
  • Andreas LieseCorporate Compliance Manager
  • Lauren StarrHead of Communications
  • Ms. Monika CasanovaChief Human Resources Officer · b. 1979
  • Christophe ChevalierHead of Capex & Strategic Projects
  • Krister SvardChief Information Security Officer & Global IT Services VC

Financials

Income Statement

Currency: EUR2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue179.57M202.61M224.30M282.13M280.98M320.37M338.69M391.87M
Growth (%)-+12.83%+10.70%+25.78%-0.41%+14.02%+5.72%+15.70%
Cost of Revenue117.45M131.04M151.11M182.43M228.99M315.60M299.42M327.55M
Gross Profit62.12M71.57M73.19M99.70M51.99M4.77M39.27M64.32M
Gross Margin34.60%35.33%32.63%35.34%18.50%1.49%11.59%16.41%
Operating Expense34.36M38.02M28.88M35.53M39.38M41.24M46.63M56.90M
Operating Income27.76M33.55M44.31M64.17M12.61M-36.47M-7.36M7.41M
Operating Margin15.46%16.56%19.76%22.74%4.49%-11.38%-2.17%1.89%
EBITDA42.59M49.28M58.55M83.35M35.72M-22.15M28.42M44.42M
EBITDA Margin23.72%24.32%26.10%29.54%12.71%-6.91%8.39%11.34%
Net Income23.82M25.74M31.34M47.26M7.77M-51.44M-19.56M-21.31M
Net Income Margin13.26%12.70%13.97%16.75%2.76%-16.06%-5.78%-5.44%
R&D12.31M14.38M1.31M1.41M1.24M1.47M1.09M2.30M
R&D as % of Total Revenue6.85%7.09%0.58%0.50%0.44%0.46%0.32%0.59%
Interest Expense4.12M3.24M3.31M2.82M3.43M7.17M16.75M18.44M
Interest Expense % of Total Revenue2.29%1.60%1.48%1.00%1.22%2.24%4.95%4.70%

Balance Sheet

Currency: EUR2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets283.83M305.14M375.98M595.04M575.78M689.09M756.58M825.31M
Total Liabilities136.15M155.73M198.31M173.87M154.10M307.86M399.33M484.98M
Total Equity147.67M37.35M177.66M421.17M421.68M381.23M357.24M340.33M
Cash10.04M17.51M17.21M136.30M37.53M95.71M68.28M74.53M
Total Debt43.26M35.36M51.83M18.00M30.63M113.66M94.12M130.46M
Net Debt33.23M17.85M34.62M-118.30M-16.31M17.96M25.84M55.93M

Cash Flow

Currency: EUR2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow22.94M55.60M49.48M57.35M5.46M36.48M89.40M78.02M
Investing Cash Flow-18.59M-12.26M-42.56M-80.84M-78.44M-59.51M-91.02M-112.44M
Financing Cash Flow-3.33M-35.94M-6.73M130.93M-26.87M84.55M-25.32M34.01M
Capital Expenditure18.30M19.70M40.62M77.71M78.76M56.73M86.97M108.46M
Free Cash Flow4.64M35.90M8.86M-20.36M-73.30M-20.25M2.43M-30.44M
Dividends Paid-9.67M9.67M14.99M9.67M0--
FCF to OCF20.25%64.56%17.91%-35.49%-1342.56%-55.50%2.72%-39.02%
Dividend Paid to FCF-26.94%109.14%-73.62%-13.19%0.00%--

Earnings

Report DateMar 1, 2025Aug 12, 2025Dec 31, 2025Mar 9, 2027
EPS Estimate0.00---
EPS Actual-0.24-0.800.16-
Surprise----
Timing-After-hours-Pre-market

Key Statistics & Ratios

Market Cap1.46B
Enterprise Value1.53B
Trailing P/E107.56
Forward P/E34.84
Price / Sales3.17
Price / Book4.41
EPS0.41
Book Value10.06
Revenue (TTM)458.86M
Gross Profit (TTM)104.91M
EBITDA75.45M
Profit Margin3.15%
Operating Margin9.29%
Return on Equity4.24%
Return on Assets3.38%
Shares Outstanding33.02M
Shares Float12.97M
Beta1.00
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20221×
0.30Apr 28, 2022